carmustine has been researched along with novobiocin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrows, LR; Ireland, CM; Kokoshka, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Cathcart, KN; Eder, JP; Frei, E; Holden, SA; Schnipper, LE; Teicher, BA | 1 |
Cathcart, KN; Eder, JP; Holden, SA; Schnipper, LE; Teicher, BA | 1 |
Ali-Osman, F; Berger, MS; Livingston, RB; Rajagopal, S; Spence, A | 1 |
7 other study(ies) available for carmustine and novobiocin
Article | Year |
---|---|
Cell-based screen for identification of inhibitors of tubulin polymerization.
Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Formazans; Glioma; Rats; Tubulin; Tumor Cells, Cultured | 1996 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cell Survival; Cyclophosphamide; Fibrosarcoma; Male; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Novobiocin; Organoplatinum Compounds | 1989 |
Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Survival; Cisplatin; Cricetinae; Cricetulus; DNA; Drug Synergism; Female; Fibrosarcoma; Leukemia L1210; Mice; Novobiocin; Ovary; Topoisomerase II Inhibitors | 1987 |
Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
Topics: Carmustine; Cell Survival; Cisplatin; DNA; DNA Repair; Glioblastoma; Humans; Novobiocin; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1993 |